Biotech News

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Quest Diagnostics (DGX)Quest DiagnosticsEarnings

Quest Diagnostics (DGX) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is quest-diagnostics.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

Quest Diagnostics

Diagnostic Information Services Leader Quest Diagnostics provides laboratory testing and diagnostic insights to physicians, hospitals, consumers, and population-health partners. Its core value lies in converting testing data into information that supports disease detection, treatment decisions, and health management. Consumer Access...

Recent company news

Stock data

Close
238.50 USD
Market cap
21.38B USD
Exchange
NYSE
Sector
MedTech
Location
Secaucus, New Jersey